Company: CWAN
Filing Date: 2025-01-13
Form Type: 425
Source: 0001193125-25-004988
Chunk: 5

Company: Clearwater Analytics Holdings, Inc.
Filing Date: 2025-01-13
Form: 425
Chunk 5
---
 provide investors with information regarding its terms. They are not intended to provide any other factual information about the Company, Acquirer, Merger Sub, Merger Sub II, Enfusion, Enfusion Operating Company or their respective affiliates. The representations, warranties and covenants contained in the Merger Agreement were made only for purposes of the Merger Agreement as of the specific dates therein, were solely for the benefit of the parties to the Merger Agreement, may be subject to limitations agreed upon by the contracting parties, including being qualified by confidential disclosures made for the purposes of allocating contractual risk between the parties to the Merger Agreement instead of establishing these matters as facts, and may be subject to standards of materiality applicable to the contracting parties that differ from those applicable to investors. Investors should not rely on the representations, warranties and covenants or any descriptions thereof as characterizations of the actual state of facts or condition of the parties thereto or any of their respective subsidiaries or affiliates. Moreover, information concerning the subject matter of representations and warranties may change after the date of the Merger Agreement, which subsequent information may or may not be fully reflected in the Company’s or Enfusion’s public disclosures. Accordingly, the Merger Agreement should not be read alone, but should instead be read in conjunction with the other information regarding the Company, Acquirer, Merger Sub, Merger Sub II, Enfusion and Enfusion Operating Company and the transactions contemplated by the Merger Agreement contained in or incorporated by reference into the filings that the Company and Enfusion have made or will make with the U.S. Securities and Exchange Commission (the “SEC”), including the Annual Reports on Form 10-Kof each of the Company and Enfusion, the Registration Statement on Form S-4(the “Registration Statement”) to be filed by the Company to register the shares of the Company’s common stock to be issued pursuant to the Mergers, which will include a prospectus of the Company and a proxy statement of Enfusion (the “proxy statement/prospectus”), and other documents that the Company and Enfusion have filed or will file with the SEC. Support Agreements In connection with entering into the Merger Agreement, on January 10, 2025, the Company entered into support agreements with each of FTV IV, L.P., a Delaware limited partnership, FTV Investment Holdings, L.P., a Delaware limited partnership, ISP V-BEF LP, a Delaware limited partnership, ISP V Main Fund EF LLC, a Delaware limited liability company, ICONIQ Strategic